Dongyuan Xing

5.5k total citations
44 papers, 2.3k citations indexed

About

Dongyuan Xing is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Dongyuan Xing has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Surgery and 21 papers in Genetics. Recurrent topics in Dongyuan Xing's work include Diabetes Management and Research (27 papers), Pancreatic function and diabetes (23 papers) and Diabetes and associated disorders (21 papers). Dongyuan Xing is often cited by papers focused on Diabetes Management and Research (27 papers), Pancreatic function and diabetes (23 papers) and Diabetes and associated disorders (21 papers). Dongyuan Xing collaborates with scholars based in United States, United Kingdom and Japan. Dongyuan Xing's co-authors include Roy W. Beck, William V. Tamborlane, Katrina J. Ruedy, Bruce A. Buckingham, Nelly Mauras, Stuart A. Weinzimer, Craig Kollman, Craig Kollman, Michael Tansey and Kellee M. Miller and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Dongyuan Xing

44 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongyuan Xing United States 25 1.9k 1.3k 1.2k 135 108 44 2.3k
Agnieszka Szadkowska Poland 22 1.1k 0.6× 770 0.6× 868 0.7× 118 0.9× 225 2.1× 147 1.9k
Sue A. Brown United States 24 947 0.5× 704 0.5× 583 0.5× 126 0.9× 228 2.1× 69 1.6k
Pieter Gillard Belgium 24 1.6k 0.9× 1.5k 1.2× 1.2k 1.0× 44 0.3× 236 2.2× 101 2.3k
Indraneel Banerjee United Kingdom 23 1.3k 0.7× 493 0.4× 410 0.4× 201 1.5× 454 4.2× 110 1.9k
Nataša Bratina Slovenia 29 2.0k 1.1× 1.6k 1.2× 1.4k 1.2× 20 0.1× 156 1.4× 82 2.5k
Oliver Blankenstein Germany 28 1.1k 0.6× 491 0.4× 363 0.3× 144 1.1× 534 4.9× 89 2.1k
Daniel R. Cherñavvsky United States 21 1.2k 0.6× 997 0.7× 762 0.7× 16 0.1× 285 2.6× 37 1.7k
Sylvia Franc France 21 1.0k 0.5× 583 0.4× 383 0.3× 52 0.4× 147 1.4× 70 1.5k
Wei Zhu China 22 1.1k 0.6× 418 0.3× 426 0.4× 21 0.2× 277 2.6× 75 1.8k
Anne Wojtusciszyn France 19 853 0.5× 832 0.6× 584 0.5× 25 0.2× 262 2.4× 53 1.5k

Countries citing papers authored by Dongyuan Xing

Since Specialization
Citations

This map shows the geographic impact of Dongyuan Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyuan Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyuan Xing more than expected).

Fields of papers citing papers by Dongyuan Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyuan Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyuan Xing. The network helps show where Dongyuan Xing may publish in the future.

Co-authorship network of co-authors of Dongyuan Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Dongyuan Xing. A scholar is included among the top collaborators of Dongyuan Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongyuan Xing. Dongyuan Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, T.R. Jeffry, Masatoshi Kudo, Ann‐Lii Cheng, et al.. (2024). ctDNA analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib (LEN) or sorafenib (SOR) as 1L therapy.. Journal of Clinical Oncology. 42(16_suppl). 4094–4094. 1 indexed citations
2.
Voss, Martin H., Thomas Powles, Bradley A. McGregor, et al.. (2022). Impact of subsequent therapies in patients (pts) with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (LEN + PEMBRO) or sunitinib (SUN) in the CLEAR study.. Journal of Clinical Oncology. 40(16_suppl). 4514–4514. 4 indexed citations
3.
Tolaney, Sara M., Kevin Kalinsky, Virginia Kaklamani, et al.. (2021). Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study. Clinical Cancer Research. 27(11). 3061–3068. 90 indexed citations
4.
5.
Ettinger, Alan B., Haichen Yang, Betsy Williams, et al.. (2015). Review of Suicidality Events in Perampanel Clinical Studies (S31.001). Neurology. 84(14_supplement). 2 indexed citations
6.
Rogawski, Michael A., Haichen Yang, Reginald V. Fant, et al.. (2015). Perampanel Discontinuation Is Not Associated With Self-Reported Withdrawal Symptoms in Patients Completing Phase III Clinical Studies (P1.232). Neurology. 84(14_supplement). 1 indexed citations
7.
Xing, Dongyuan, Yangxin Huang, Henian Chen, et al.. (2015). Bayesian inference for two-part mixed-effects model using skew distributions, with application to longitudinal semicontinuous alcohol data. Statistical Methods in Medical Research. 26(4). 1838–1853. 11 indexed citations
8.
Glauser, Tracy A., Antonio Laurenza, Haichen Yang, et al.. (2014). Efficacy and Safety of Adjunctive Perampanel Based on Number of Antiepileptic Drugs at Baseline (P3.273). Neurology. 82(10_supplement). 1 indexed citations
9.
Sequeira, Paola A., Lucy Montoya, Valerie Ruelas, et al.. (2013). Continuous Glucose Monitoring Pilot in Low-Income Type 1 Diabetes Patients. Diabetes Technology & Therapeutics. 15(10). 855–858. 34 indexed citations
10.
Miller, Kellee M., Dongyuan Xing, William V. Tamborlane, Richard M. Bergenstal, & Roy W. Beck. (2013). Challenges and Future Directions of the T1D Exchange Clinic Network and Registry. Journal of Diabetes Science and Technology. 7(4). 963–969. 9 indexed citations
11.
Arbeláez, Ana María, Dongyuan Xing, Philip E. Cryer, et al.. (2013). Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. Pediatric Diabetes. 15(2). 127–134. 47 indexed citations
12.
Sherr, Jennifer L., William V. Tamborlane, Dongyuan Xing, et al.. (2012). Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual β-Cell Function. Diabetes Care. 35(4). 817–820. 19 indexed citations
13.
Xing, Dongyuan, Craig Kollman, Roy W. Beck, et al.. (2011). Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 13(3). 351–358. 103 indexed citations
14.
Wilson, Darrell M., Dongyuan Xing, Bruce W. Bode, et al.. (2011). Hemoglobin A1c and Mean Glucose in Patients With Type 1 Diabetes. Diabetes Care. 34(3). 540–544. 42 indexed citations
15.
Beck, Roy W., Michael W. Steffes, Dongyuan Xing, et al.. (2011). The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Pediatric Diabetes. 12(8). 690–695. 40 indexed citations
16.
Tsalikian, Eva, Larry A. Fox, Stuart A. Weinzimer, et al.. (2011). Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatric Diabetes. 13(4). 301–307. 59 indexed citations
17.
Lee, Joyce M., Michael J. O’Grady, Anirban Basu, et al.. (2011). Health Utilities for Children and Adults With Type 1 Diabetes. Medical Care. 49(10). 924–931. 32 indexed citations
18.
Wilson, Darrell M., H. Peter Chase, Craig Kollman, et al.. (2008). Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes. Pediatric Diabetes. 9(4pt1). 320–325. 10 indexed citations
19.
Buckingham, Bruce A., Roy W. Beck, William V. Tamborlane, et al.. (2007). Continuous Glucose Monitoring in Children with Type 1 Diabetes. The Journal of Pediatrics. 151(4). 388–393.e2. 107 indexed citations
20.
Tansey, Michael, Roy W. Beck, Bruce A. Buckingham, et al.. (2005). Accuracy of the Modified Continuous Glucose Monitoring (CGMS ® ) Sensor in an Outpatient Setting: Results from a Diabetes Research in Children Network (DirecNet) Study. Diabetes Technology & Therapeutics. 7(1). 109–114. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnieszka Szadkowska Breakdown of academic impact, for papers by Sue A. Brown Breakdown of academic impact, for papers by Pieter Gillard Breakdown of academic impact, for papers by Indraneel Banerjee Breakdown of academic impact, for papers by Nataša Bratina Breakdown of academic impact, for papers by Oliver Blankenstein Breakdown of academic impact, for papers by Daniel R. Cherñavvsky Breakdown of academic impact, for papers by Sylvia Franc Breakdown of academic impact, for papers by Wei Zhu Breakdown of academic impact, for papers by Anne Wojtusciszyn
Rankless by CCL
2026